Kansas City, MO,
19
November
2018
|
17:28 PM
Europe/Amsterdam

Drs. Abdel-Rahman and Lewis Named to ASCPT Leadership Positions

The American Society for Clinical Pharmacology and Therapeutics (ASCPT) has selected two Children's Mercy faculty to serve in key leadership positions.

Dr. Abdel-Rahman chosen as ASCPT President-Elect
Susan Abdel-Rahman, PharmD, Professor, Section Chief, and Director of Innovation in Health Care Delivery for the Children's Research Institute, has been selected as the incoming President-Elect for the American Society of Clinical Pharmacology and Therapeutics. As a member, Dr. Rahman has served on the Education Committee, Scientific Awards Committee, Board of Directors, and most recently as Chair of the Scientific Program committee. She has been responsible for developing several junior and mid-career initiatives, including mentoring and leadership programs. In March, Dr. Rahman will become a member of the ASCPT Executive Committee and an ex efficio member of other Board-designated committees and she will take the reins as President of the Society at the Annual Meeting in 2020.

Dr. Lewis appointed to ASCPT Board of Directors
Tamorah Lewis, MD, PhD, Assistant Professor, Divisions of Neonatology and Clinical Pharmacology, Toxicology, and Therapeutic Innovation, was recently selected to serve as a Director At-Large on the Board of Directors for ASCPT. Dr. Lewis is one of three new board members slated to start their term in March of 2019. Dr. Lewis has been a member of ASCPT since 2011 and has served as a member of the Scientific Program Committee. In addition to her ASCPT service, Dr. Lewis sits on the Executive Committee for the AAP Section of Clinical Pharmacology and Therapeutics and is an ad hoc member of the FDA's Pediatric Advisory Committee.

Founded in 1900, the ASCPT is one of the oldest and largest scientific and professional organizations serving the disciplines of clinical pharmacology and translational medicine.

 

About Us

Children’s Mercy Kansas City is an independent, non-profit, 386-bed pediatric health system, providing over half a million patient encounters each year for children from across the country. Children’s Mercy is ranked by U.S. News & World Report in nine specialties. We have received Magnet® recognition five times for excellence in nursing services. In affiliation with the University of Missouri-Kansas City, our faculty of more than 800 pediatric specialists and researchers is actively involved in clinical care, pediatric research and educating the next generation of pediatricians and pediatric subspecialists. The Children’s Mercy Research Institute (CMRI) integrates research and clinical care with nationally recognized expertise in genomic medicine, precision therapeutics, population health and health care innovation. In 2021 the CMRI moved into a nine-story, 375,000-square-foot space emphasizing a translational approach to research in which clinicians and researchers work together to accelerate the pace of discovery that enhances care.